TORONTO, Ontario — March 11, 2026
Younet.ai, a Toronto-based artificial intelligence technology company specializing in enterprise-grade private large language model (LLM) infrastructure, announced a major milestone in the development of autonomous research agents for biotechnology and life sciences. The company highlighted how the release of AutoResearch, an open-source tool created by AI researcher Andrej Karpathy, reinforces the technological foundation behind Researgency.ai, an agentic AI research platform being developed in collaboration with Kala Bio. The breakthrough demonstrates how AI agents can autonomously conduct more than 100 machine-learning experiments overnight, signaling a potential transformation in how life-science research and development processes are designed, simulated, and optimized.
Autonomous Research Agents Transform Scientific Experimentation
The emergence of AutoResearch provides a public example of how autonomous AI agents can accelerate scientific discovery through continuous experimentation loops. The system allows artificial intelligence agents to independently modify code, run machine-learning experiments, evaluate outcomes, and refine future iterations, enabling high-frequency experimentation that can exceed 100 research experiments overnight using a single GPU.
This approach represents a shift from traditional human-limited research cycles to always-on computational experimentation, dramatically increasing the speed at which hypotheses can be tested and optimized. Instead of researchers manually running experiments sequentially, AI agents can execute multiple experiments in parallel, evaluate results in real time, and automatically retain successful improvements while discarding ineffective outcomes.
Industry observers believe such capabilities could transform not only machine learning research but also biotechnology R&D workflows, where experimental design, protocol optimization, and scenario modeling often require significant time and resources. By enabling continuous iteration and automated decision evaluation, autonomous research agents may allow scientists to explore vastly larger experimental design spaces than previously possible.
Advertisement
Researgency.ai Brings Autonomous Research to Biotech R&D
Building on these principles, Younet.ai is developing the Researgency.ai platform with Kala Bio, a biopharmaceutical company focused on innovative approaches to drug development. The platform aims to apply autonomous research loops to biotechnology R&D planning, allowing AI agents to simulate complex study scenarios and optimize research strategies around the clock.
Through Researgency.ai, the concept of “100 experiments overnight” in machine learning becomes “100 study scenarios overnight” in life sciences research. AI agents can automatically generate and evaluate potential clinical or preclinical research configurations, considering factors such as study endpoints, patient enrollment feasibility, statistical power, budgets, and timelines.
Once objectives and constraints are defined by human researchers, the AI system executes a continuous agentic research loop that generates protocol variations, simulates outcomes, and ranks possible research strategies according to predefined success metrics. By morning, research teams receive prioritized recommendations and optimized protocol designs, allowing scientists to make more informed strategic decisions based on a large number of simulated scenarios.
This autonomous approach has the potential to significantly improve research planning efficiency, helping biotechnology companies reduce trial design timelines and identify more effective study configurations before clinical development begins.
A New Paradigm for Continuous AI-Driven Research
The collaboration between Younet.ai and Kala Bio reflects a broader trend toward AI-driven automation in scientific research and drug development. In traditional research environments, study planning and protocol optimization often occur through iterative discussions, simulations, and manual modeling processes. Autonomous AI research systems introduce a new paradigm in which computational agents continuously explore and refine potential research pathways without human intervention.
Early demonstrations of the AutoResearch framework have already illustrated the potential of autonomous experimentation. In one public example, a company reported that an AI-driven research loop produced a 19 percent improvement in validation scores overnight, with an AI-optimized model outperforming a manually tuned alternative. Such results highlight the possibility that agentic AI systems may deliver compounding improvements in complex optimization tasks, including scientific discovery and biotechnology research planning.
For life-science organizations, this approach could fundamentally reshape how R&D decisions are made. By enabling 24-hour autonomous experimentation and scenario simulation, AI agents may dramatically accelerate the pace of innovation while allowing researchers to focus on strategic interpretation rather than repetitive experimental execution.
As the Researgency.ai platform continues to evolve, Younet.ai and Kala Bio aim to demonstrate how autonomous research agents can support faster, data-driven decision-making across the biotechnology industry. By combining private LLM infrastructure, retrieval-augmented generation (RAG), and multi-agent research frameworks, the companies hope to usher in a new era of AI-enabled scientific discovery, where experimentation, analysis, and optimization occur continuously across global research ecosystems.
z
Source: Younet.ai press release
